Schistosoma mansonischistosomula antigens induce Th1/Pro-inflammatory cytokine responses

Author:

Egesa Moses12,Lubyayi Lawrence2,Tukahebwa Edridah M.3,Bagaya Bernard S.4,Chalmers Iain W.5,Wilson Shona6,Hokke Cornelis H.7,Hoffmann Karl F.5,Dunne David W.6,Yazdanbakhsh Maria7,Labuda Lucja A.7,Cose Stephen28ORCID

Affiliation:

1. Department of Medical Microbiology; School of Biomedical Sciences; Makerere University College of Health Sciences; Kampala Uganda

2. Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit; Entebbe Uganda

3. Vector Control Division; Ministry of Health; Kampala Uganda

4. Department of Immunology and Molecular Biology; School of Biomedical Sciences; Makerere University College of Health Sciences; Kampala Uganda

5. Institute of Biological, Environmental & Rural Sciences; Aberystwyth University; Aberystwyth UK

6. Department of Pathology; University of Cambridge; Cambridge UK

7. Department of Parasitology; Leiden University Medical Center; Leiden The Netherlands

8. Department of Clinical Research; London School of Hygiene & Tropical Medicine; London UK

Funder

Wellcome Trust

DELTAS Africa Initiative

UK Government

New Partnership for Africa's Development

TheSchistoVac

Seventh Framework Programme

Publisher

Wiley

Subject

Immunology,Parasitology

Reference58 articles.

1. Schistosomiasis and soil-transmitted helminthiases number of people treated in 2016;WHO;Wkly Epidemiol Rec,2017

2. Repeated praziquantel treatments remodel the genetic and spatial landscape of schistosomiasis risk and transmission;Barbosa;Int J Parasitol,2016

3. Reduced efficacy of praziquantel against Schistosoma mansoni is associated with multiple rounds of mass drug administration;Crellen;Clin Infect Dis,2016

4. In vitro praziquantel test capable of detecting reduced in vivo efficacy in Schistosoma mansoni human infections;Lamberton;Am J Trop Med Hyg,2010

5. Schistosomiasis elimination strategies and potential role of a vaccine in achieving global health goals;Mo;Am J Trop Med Hyg,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3